Why Eviti Connect for Autoimmune?

Autoimmune therapies are complex, costly, and rapidly evolving

Eviti Connect brings clarity and confidence to every autoimmune regimen, pairing an expert-curated evidence library with intelligent automation to support member-centric, cost-effective care.

Evidence-based
Biosimilar redirection
Actionable data

A large, complex, and costly population

Autoimmune conditions affect tens of millions of Americans and drive a disproportionate share of specialty drug spend, making evidence-based management essential.

  • 50M+

    Americans live with an autoimmune disease.1

  • $52B+

    Expected annual U.S. spend on autoimmune medicines by 2027.2

  • 100+

    Known autoimmune diseases, just 7 account for $51.8–70.6B in annual cost.1

  • FDA

    Every drug in the Eviti autoimmune library is FDA-approved for its condition.

Rheumatologist reviewing autoimmune treatment options

Clarity and confidence for every autoimmune regimen

The Eviti autoimmune library covers the most commonly prescribed drugs, including biosimilars, across the most prevalent conditions: inflammatory bowel disease, rheumatoid arthritis, plaque psoriasis, multiple sclerosis, and more. All are FDA-approved for their respective conditions.

  • Brand, biosimilar, and generic management for best pricing
  • Compliance with medical policy, pharmacy policy, and step therapy
  • Site-of-care redirection when clinically appropriate

Confidence and clarity for value-based care

Eviti Connect aligns care decisions, reducing complexity and improving outcomes.

  • Member Confidence

    Ensuring every treatment is delivered with clinical clarity, appropriate, evidence-based, and member-centric.

  • Provider Alignment

    Simplifying approvals and clinical pathways with transparency.

  • Collaborative Intelligence

    Data-driven expertise and technology to maximize outcomes and streamline cost management.

From submission to decision, in one workflow

A streamlined, evidence-driven process that reduces administrative burden and gets patients to therapy sooner.

  • 1

    Streamlined Submission

    Providers make prior authorization requests through Eviti Connect, starting the process with confidence.

  • 2

    Automated Validation

    Each request is instantly verified against the latest evidence-based guidelines and payer policies, automatically approving plans that align with best practices.

  • 3

    Collaborative Intelligence

    When a treatment requires additional review, Eviti combines clinical intelligence with peer-to-peer dialogue to support the best possible care.

Human judgment, amplified by technology

Our team maintains rigorous care processes without compromising what matters most: the human experience.

  • Clinical Judgment

    Expert clinical reviewers, including board-certified physicians and certified nurses, review every treatment plan with care.

  • Trusted Approvals

    Confidence in every decision, enabled by a trusted clinical resource that validates evidence-based treatment.

  • Advanced Automation

    Technology integrates with the Eviti Library, payer preferences, and medical policies to streamline authorization.

Care team collaborating on autoimmune treatment decision

Reliable authorizations. Responsible cost. Faster therapy.

Eviti Connect’s intelligent, automated process delivers reliable authorizations for payers and providers, ensures appropriate reimbursement, and limits appeals and denials, helping patients with autoimmune diseases begin treatment without delay.

Five ways Eviti Connect delivers confidence in autoimmune care

  • Deliver Evidence-Based, Personalized Care

    Empower providers with real-time, evidence-based regimens tailored to each patient’s autoimmune diagnosis, ensuring high-quality care.

  • Drive Responsible Cost Management

    Reduce unnecessary spend by aligning treatment decisions with evidence-based guidelines and redirecting to clinically equivalent options.

  • Accelerate Biosimilar Adoption

    Support formulary goals by guiding providers toward approved biosimilar alternatives at the point of prescribing.

  • Streamline Prior Authorizations

    Automate evidence-based approvals to reduce turnaround time, minimize denials and appeals, and get patients started on therapy sooner.

  • Unlock Actionable Clinical Data

    Gain visibility into prescribing patterns, treatment trends, and cost drivers across your autoimmune population.

Ready to bring clarity to autoimmune care?

Schedule a 20-minute walkthrough with our Eviti team. We’ll demo real authorization workflows from your specialty mix, no slides.

Request a Demo